Our data demonstrate that SH3BP5-high DLBCL tumors exhibit significantly reduced infiltration of anti-tumor immune effectors, such as CD8 + T cells, alongside decreased stromal-immune scores and increased tumor purity. Here, SH3BP5 is linked to diffuse large B-cell lymphoma.